•  
•  
•  
•  
•  

Sharing our research with the field and helping to shape the discussion of best practices in the treatment of cancer patients with cancer is a key focus of NMCR Analytics. This is evidenced by our presentations at major congresses. Recent work includes:

Management of N3 stage IIIB NSCLC: Changes in U.S. physician behavior following ASCO 2007.
Abstract: #7579
2008 ASCO Annual Meeting
View poster

Patterns of planned post-operative management among U.S. medical oncologists (USMO) after neo-adjuvant chemoradiotherapy (nCRT) and surgery for stage III rectal cancer (RC).
Abstract: #6602
2008 ASCO Annual Meeting
View poster

Impact of 2006 ASCO Annual Meeting data release of Cancer and Leukemia Group B (CALGB) protocol 9633 on practice patterns in the United States.
Abstract: #7547
2008 ASCO Annual Meeting
View poster

Three-year analysis of the use of erlotinib combined with gemcitabine as first-line therapy in patients with advanced pancreatic cancer.
Abstract: #209
2008 ASCO Gastrointestinal Cancers Congress
View poster